Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review
- PMID: 38657793
- DOI: 10.1016/j.eprac.2024.04.007
Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review
Abstract
Background: While clinical features of KCNJ5-mutated aldosterone-producing adenoma (APA) have been reported, evidence of its clinical outcomes is lacking. We aimed to synthesize available literature about the associations between KCNJ5 mutation with cardiovascular and metabolic outcomes among patients with APA.
Methods: In this systematic review of observational studies, MEDLINE and Embase were searched through August 2022. Two independent authors screened the search results and extracted data from eligible observational studies investigating cardiovascular or metabolic outcomes between KCNJ5-mutated APAs and KCNJ5-non-mutated APAs. Risk of Bias In Non-randomized Studies of Interventions was used to assess the quality of the included studies.
Results: A total of 573 titles/abstracts were screened and after the expert opinion of the literature, full text was read in 20 titles/abstracts, of which 12 studies were included. Across 3 studies comparing the baseline or change in the cardiac function between KCNJ5-mutated APAs and KCNJ5-non-mutated APAs, all studies reported the association between impaired cardiac functions and KCNJ5 mutation status. Among 6 studies evaluating the cure of hypertension after surgery, all studies showed that KCNJ5 mutation was significantly associated with the cure of hypertension. In quality assessment, 7 studies were at serious risk of bias, while the remaining studies were at moderate risk of bias.
Conclusions: This systematic review provided evidence of the significant association between KCNJ5 mutation and unfavorable cardiovascular outcomes in patients with primary aldosteronism. Further research is needed to improve the quality of evidence on this topic and elucidate the underlying mechanisms of the potential burden of KCNJ5 mutation.
Keywords: KCNJ5; aldosterone producing adenoma; cardiovascular outcome; hypertension; primary aldosteronism.
Copyright © 2024 AACE. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no multiplicity of interest to disclose.
Similar articles
-
Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.Hypertension. 2018 Sep;72(3):632-640. doi: 10.1161/HYPERTENSIONAHA.118.10907. Hypertension. 2018. PMID: 30354756 Free PMC article.
-
Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.J Steroid Biochem Mol Biol. 2022 Jul;221:106116. doi: 10.1016/j.jsbmb.2022.106116. Epub 2022 May 6. J Steroid Biochem Mol Biol. 2022. PMID: 35533918
-
GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.J Clin Endocrinol Metab. 2018 Mar 1;103(3):813-823. doi: 10.1210/jc.2017-00950. J Clin Endocrinol Metab. 2018. PMID: 29165597
-
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism.Front Endocrinol (Lausanne). 2023 Mar 6;14:1061704. doi: 10.3389/fendo.2023.1061704. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36950676 Free PMC article. Review.
-
New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.Curr Opin Nephrol Hypertens. 2013 Mar;22(2):141-7. doi: 10.1097/MNH.0b013e32835cecf8. Curr Opin Nephrol Hypertens. 2013. PMID: 23318698 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources